APA (7th ed.) Citation

PO, H., R, M., GG, R., AP, Z., AM, S., A, K., . . . KS, K. (2025). Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of Nephrotoxicity. Clinical pharmacology and therapeutics, 118(4), 841. https://doi.org/10.1002/cpt.3729

Chicago Style (17th ed.) Citation

PO, Hanafin, et al. "Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of Nephrotoxicity." Clinical Pharmacology and Therapeutics 118, no. 4 (2025): 841. https://doi.org/10.1002/cpt.3729.

MLA (9th ed.) Citation

PO, Hanafin, et al. "Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of Nephrotoxicity." Clinical Pharmacology and Therapeutics, vol. 118, no. 4, 2025, p. 841, https://doi.org/10.1002/cpt.3729.